Prevent more strokes with a daily anti-clotting heart pill
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 3 trial tests whether a daily “polypill” can reduce the chance of another stroke after a recent ischemic stroke. It may help people by improving several heart-and-blood-vessel risks at once, but only if it fits safely with their medical situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older and able to understand and sign consent
- Have had an ischemic stroke (not bleeding in the brain) within the last 2 months
- Have at least one added heart risk condition, such as diabetes, high blood pressure, mild–moderate kidney problems, or a prior heart attack
- Not have a known reason you cannot take any part of the study “polypill”
- Not have major exclusions like hemorrhagic (bleeding) stroke, severe heart failure, or very severe kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether a daily “polypill” plus a simple home risk-check plan can lower the chance of stroke and future thinking/memory problems. It is aimed at adults at moderate risk but who have not had stroke or heart disease before.
This study tests whether the drug cilostazol, when added to your usual aspirin or clopidogrel, can help prevent another stroke. It is being done in Africa and may be a good option if you've recently had a stroke or mini-stroke and want to lower your risk of another one.
This trial looks at how a daily “polypill” affects coronary (heart blood vessel) risk factors in adults who already take this polypill for prevention after a prior heart event. If you’re eligible, you’ll complete several study visits so the team can compare risk factors over time.
This study tests a single daily pill combining several medicines to lower blood pressure and cholesterol in people with type 2 diabetes. Taking one pill may be easier than taking multiple medicines, which could help you stay healthy.
This study tests a single pill that combines three heart medicines—aspirin, a blood thinner, and a statin—to see if it helps people who have had a heart attack or stent procedure. It aims to make it easier to take your daily heart medications.
This trial tests a combination pill (polypill) and a medicine called colchicine to see if they can lower the risk of future heart attacks, strokes, or other artery problems. It is for people who already have a history of heart or blood vessel disease.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.